|
|
| (53 intermediate revisions not shown) |
| Line 2: |
Line 2: |
| | {{https://2011.igem.org/Team:Peking_R/bannerhidden}} | | {{https://2011.igem.org/Team:Peking_R/bannerhidden}} |
| | {{https://2011.igem.org/Team:Peking_R/back2}} | | {{https://2011.igem.org/Team:Peking_R/back2}} |
| - | {{https://2011.igem.org/Team:Peking_R/Projectbackground}} | + | {{https://2011.igem.org/Team:Peking_R/Projectbackground2}} |
| | <html xmlns="http://www.w3.org/1999/xhtml"> | | <html xmlns="http://www.w3.org/1999/xhtml"> |
| | <head> | | <head> |
| Line 13: |
Line 13: |
| | top:319px; | | top:319px; |
| | width:640px; | | width:640px; |
| - | height:4558px; | + | height:921px; |
| | z-index:1; | | z-index:1; |
| | font-family: Georgia, "Times New Roman", Times, serif; | | font-family: Georgia, "Times New Roman", Times, serif; |
| | font-size: 16px; | | font-size: 16px; |
| - | text-align: left; | + | text-align: justify; |
| - | color: #000; | + | color: #333; |
| | background-color: #FFF; | | background-color: #FFF; |
| | } | | } |
| Line 29: |
Line 29: |
| | .mainbody { | | .mainbody { |
| | text-align: justify; | | text-align: justify; |
| - | font-size: 16px;
| |
| - | font-family: Georgia, "Times New Roman", Times, serif;
| |
| | } | | } |
| | .project { | | .project { |
| Line 47: |
Line 45: |
| | #apDiv1 .notbookmaintitle { | | #apDiv1 .notbookmaintitle { |
| | font-family: "Arial Black", Gadget, sans-serif; | | font-family: "Arial Black", Gadget, sans-serif; |
| - | font-size: 24px; | + | font-size: 29px; |
| | } | | } |
| | #apDiv2 { | | #apDiv2 { |
| | position:absolute; | | position:absolute; |
| - | left:65px; | + | left:12px; |
| - | top:815px; | + | top:-4px; |
| | width:610px; | | width:610px; |
| - | height:443px; | + | height:188px; |
| | z-index:2; | | z-index:2; |
| | } | | } |
| - | #apDiv3 {
| + | .TPP { font-family: Arial, Helvetica, sans-serif; |
| - | position:absolute;
| + | |
| - | left:59px;
| + | |
| - | top:432px;
| + | |
| - | width:562px;
| + | |
| - | height:171px;
| + | |
| - | z-index:3;
| + | |
| | } | | } |
| - | .exist { | + | .TPPQ { font-weight: bold; |
| | font-family: Arial, Helvetica, sans-serif; | | font-family: Arial, Helvetica, sans-serif; |
| - | font-size: 24px;
| |
| - | font-weight: bold;
| |
| | } | | } |
| - | .TPP { | + | .exist { |
| | font-family: Arial, Helvetica, sans-serif; | | font-family: Arial, Helvetica, sans-serif; |
| - | }
| + | font-size: 19px; |
| - | .TPPQ {
| + | |
| | font-weight: bold; | | font-weight: bold; |
| | } | | } |
| - | .TITLE2 {
| + | #apDiv3 { position:absolute; |
| - | text-align: center; | + | left:60px; |
| - | font-family: Arial, Helvetica, sans-serif; | + | top:404px; |
| - | font-size: 18px; | + | width:631px; |
| - | color: #000; | + | height:171px; |
| | + | z-index:3; |
| | } | | } |
| - | .picturemark {
| + | #apDiv4 { position:absolute; |
| - | font-size: 14px; | + | left:60px; |
| - | text-align: justify; | + | top:404px; |
| - | }
| + | width:631px; |
| - | .Reference {
| + | height:171px; |
| - | font-family: Verdana, Geneva, sans-serif; | + | z-index:3; |
| | } | | } |
| | a:link { | | a:link { |
| - | color: #F0F; | + | color: #F0C; |
| | text-decoration: none; | | text-decoration: none; |
| | } | | } |
| | a:visited { | | a:visited { |
| | text-decoration: none; | | text-decoration: none; |
| - | color: #F0F; | + | color: #F0C; |
| | } | | } |
| | a:hover { | | a:hover { |
| Line 103: |
Line 93: |
| | text-decoration: none; | | text-decoration: none; |
| | color: #F00; | | color: #F00; |
| - | }
| |
| - | .TPPQ1 { font-weight: bold;
| |
| - | font-family: Arial, Helvetica, sans-serif;
| |
| | } | | } |
| | </style> | | </style> |
| Line 112: |
Line 99: |
| | <body> | | <body> |
| | <div id="apDiv1"> | | <div id="apDiv1"> |
| - | <p class="notbookmaintitle" align=center>RNA toolkit<a name="start" id="start"></a></p> | + | <p class="notbookmaintitle" align=center> </p> |
| - | <hr />
| + | <p class="notbookmaintitle" align=center> </p> |
| - | <p> </p>
| + | <p class="notbookmaintitle" align=center> </p> |
| - | <p> </p> | + | <p class="notbookmaintitle" align=center>Overview</p> |
| - | <p> </p> | + | <hr /> |
| - | <p> </p> | + | <p>In recent years, RNA devices have emerged as powerful tools to regulate gene expression in vivo, and particularly, ligand-responsive riboswitches/ribozymes enable us to manipulate translation strength of specific genes upon different concentrations of ligands. Ligand-responsive riboswitches/ribozymes regulate the translation rate of downstream gene by changing conformations, cleaving or splicing upon external addition of ligand. Compared with transcriptional and post-translational regulation, riboswitches/ribozymes function through allostery of RNA structure, which requires little or no assistance from proteins, so the regulation mechanism is relatively simpler and their functions are more decoupled from native biological activities.</p> |
| - | <p> </p>
| + | <p> In order to fulfill the goal of establishing an extensible and versatile methodology for softcoding of genetic program, our team reached out to a great extent to search for available ligand- responsive riboswitches/ ribozymes that meet our criteria and selected them as our genetic rheostats.</p> |
| - | <p> </p>
| + | <p>Candidates for genetic rheostats must meet two basic criteria: firstly, they should possess a relatively plain dose-response curve, which would allow for precise translation strength modulation within a wide range of ligand concentration; secondly, ligands they recognize should be genetically and biochemically orthogonal to the host cells, in our case, <em>E.coli</em> cells, as much as possible.</p> |
| - | <p> </p>
| + | <p>Two candidates emerged as promising genetic rheostats that satisfied our requirements: thiamine pyrophosphate (TPP)-responsive hammerhead ribozymes and theophylline-responsive riboswitches. By altering the upstream promoter and downstream coding sequence of the genetic rheostats, we demonstrated that their performance was independent of sequence context, which proved that our genetic rheostats are modular.</p> |
| - | <hr />
| + | <p>To further extend the repertoire of our genetic rheostats, we created a ribozyme that functions with a different mechanism, which has an extreme low basal level. We substituted the aptamer domain of c-di-GMP group I intron to theophylline-responsive aptamer, thus invented a group I intron that senses theophylline to perform splicing function.</p> |
| - | <p align="center" class="TITLE2"><strong>High-performance RNA Controllers Regulated By TPP</strong></p> | + | <p>Moreover, we introduced a general method to evolve genetic rheostat that senses a new ligand. By coupling an adenine aptamer with hammerhead ribozyme and randomizing nucleotides in the linker domain, we evolved new genetic rheostat through dual selection, whose self-cleavage could be regulated by adenine.</p> |
| - | <p class="mainbody">Just as previously stated, even though proteins fulfill most of biological functions, such as enzymes as catalysts, receptors as signal transmitters, they have certain drawbacks when used as synthetic biology’s modules. One example is that they are often coupled with normal biological processes, so their functions depend much on the genetic context. RNA, as a large family of basic biomolecules, also possesses similar capacities to those of proteins.</p>
| + | |
| - | | + | |
| - | <p class="mainbody">Hammerhead ribozymes are small self-cleaving RNAs, first discovered in satellite RNAs of plant viruses that catalyze a specific phosphodiester bond isomerization reaction in the course of rolling-circle replication <a href="#r101">[1]</a>. More recently a full-length hammerhead ribozyme from <em> mansoni</em> is being more frequently utilized for application. As shown in <strong>Fig.1-A</strong>, this hammerhead ribozyme can be truncated to a minimal, catalytically active motif consisting of (marked in colors) flanking a central core of 15 mostly invariant nucleotides (marked in frame). And the conserved central bases are essential for the hammerhead ribozyme’s catalytic activity<a href="#r102"> [1]</a>. shown in <strong>Fig.1-B</strong> indicates that the secondary structure of the<em> Schistosoma</em> hammerhead ribozyme can be distorted into a uridine turn because of distant loop/bulge interaction which induces changes in stem II while simultaneously unwinding stem I. For the basic catalytic function of hammerhead ribozyme, the active site for self-cleaving of <em>Schistosoma</em> hammerhead ribozyme resides between stem III and stem I, as shown in <strong>Fig.1-A.</strong></p>
| + | |
| - | <p class="mainbody">It has been reported previously that mRNAs encoding enzymes involved in thiamine (vitamin B1) biosynthesis in <em>Escherichia coli</em> can bind derivative without the assistance from protein cofactors <a href="#r201">[2]</a>. These ligand-binding mRNAs actually possess thiamine or pyrophosphate binding domain, called aptamer, in which the binding event can bring about a conformational change which is important for genetic control. This natural thiamine pyrophosphate (TPP) aptamer can bind to TPP specifically and a defined structure is stabilized. As shown in <strong>Fig.1-C</strong>, upon addition of TPP, TPP can bind loop in green through . <strong>Fig.1-D</strong> shows the tertiary structure of natural TPP aptamer binding to TPP.</p> | + | |
| - | <p> </p> | + | |
| - | <p> </p>
| + | |
| - | <table width="618" border="0" cellspacing="0" cellpadding="0">
| + | |
| - | <tr>
| + | |
| - | <th colspan="3" scope="col"> </th>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <th width="10" scope="col"> </th>
| + | |
| - | <th width="594" scope="col"><img src="https://static.igem.org/mediawiki/2011/8/80/PekingR_Untitled.jpg" alt="" width="594" height="454" /></th>
| + | |
| - | <th width="14" scope="col"> </th>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <th colspan="3" scope="col"> </th>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td colspan="3"><p align="left"><strong>Figure.1</strong> <br />
| + | |
| - | <span class="picturemark">The schematic structures of ribozyme and natural TPP aptamer. <strong>A) </strong>The secondary structure of<em> Schistosoma</em> hammerhead ribozyme. Three base-pairing stems are shaded in colors. The part in yellow represents stem III, which is later modified to be the linker between hammerhead ribozyme and aptamer. The part in blue represents stem II, and the purple and red ones stand for two parts of stem I. The sequence in frame represents for the conserved nucleotides. The red arrow points to the scissile bond. <strong>B)</strong> The tertiary structure of<em>Schistosoma</em> hammerhead ribozyme. The cyan part indicates the fragment of mRNA after cleavage. The red one indicates the active site for self-cleavage. The linker between hammerhead ribozyme and aptamer is shown in yellow. <strong>C)</strong> The secondary structure of natural TPP aptamer. TPP can bind to loop in green through non-covalent bond and the part marked in yellow indicates the linker between hammerhead ribozyme and apatamer. <strong>D) </strong>The tertiary structure of natural TPP aptamer. The three-dimensional segment in blue is TPP, and the yellow part represents the linker between<em> Schistosoma </em>hammerhead ribozyme and natural TPP aptamer. Nucleotides that bind to TPP are shown in green.</span></p></td>
| + | |
| - | </tr>
| + | |
| - | </table>
| + | |
| - | <p> </p> | + | |
| - | <p class="mainbody">In fact, the natural aptamer domain of the TPP riboswitch can be exploited to construct very efficient that regulate gene expression, demonstrated by <a name="OLE_LINK80" id="OLE_LINK80"></a><a name="OLE_LINK79" id="OLE_LINK79"></a><a name="OLE_LINK78" id="OLE_LINK78"></a><a name="OLE_LINK77" id="OLE_LINK77">Markus Wieland <em>et. al.</em></a><a href="#r301">[3]</a>. To couple the natural TPP aptamer riboswitch with <em>Schistosoma</em> hammerhead ribozyme, stem III of <em>Schistosoma</em> hammerhead ribozyme and yellow shaded stem of TPP aptamer in <strong>Fig.1-C</strong> were modified to construct linker between hammerhead ribozyme and aptamer. The resulting artificial ribozymes functioned with high performance, whose highest fold reached 1000. </p>
| + | |
| - | <p class="mainbody">Markus Wieland <em>et. al.</em> have created several mutants of the constructed ribozyme-based TPP-responsive artificial ribozyme switches (TPP ribozyme)<a href="#r201">[3]</a>. We chose two of the mutants in our project, one of which can activate downstream gene expression upon adding TPP, numbered 1.20, and the other would inhibit downstream gene expression when TPP added, numbered 2.5. The secondary structure of TPP ribozyme 1.20 and 2.5 are shown in <strong>Fig.2</strong>. The lower part of the structure is natural TPP aptamer riboswitch, and the upper part is <em>Schistosoma</em> hammerhead ribozyme. Stem III in green indicates ribozyme, the pairing nucleotides of which is the only distinction between TPP ribozyme 1.20 and 2.5.</p>
| + | |
| - | <p> </p> | + | |
| - | <p> </p>
| + | |
| - | <p> </p>
| + | |
| - | <table width="200" border="0" cellspacing="0" cellpadding="0">
| + | |
| - | <tr>
| + | |
| - | <th rowspan="3" scope="col"> </th>
| + | |
| - | <th scope="col"> </th>
| + | |
| - | <th rowspan="3" scope="col"> </th>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <th scope="col"><img src="https://static.igem.org/mediawiki/2011/9/98/PekingR_Zyy_12.png" width="619" height="374" /></th>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <th scope="col"> </th>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td colspan="3"><p align="left" class="picturemark"><strong>Figure.2</strong><strong> </strong><br />
| + | |
| - | Secondary structure of artificial thiamine pyrophosphate (TPP) ribozymes.<strong> Left:</strong> TPP ribozyme 1.20; <strong>Right:</strong> TPP ribozyme 2.5. The natural TPP aptamer domain (blue) is fused to stem III of the <a name="OLE_LINK108" id="OLE_LINK108"></a><a name="OLE_LINK107" id="OLE_LINK107"><em>Schistosoma </em></a>hammerhead ribozyme. The linker between aptamer and hammerhead ribozyme is shown in green. Stems are indicated by roman numerals; rate-enhancing interaction between stem I and stem II are shown as gray lines; the cleavage site is marked by a red arrow. RBS is shaded in pink and the translation start code (AUG) is shaded in black. The figure was modified from<a href="#r303"> [3]</a>. </p></td>
| + | |
| - | </tr>
| + | |
| - | </table>
| + | |
| - | <p class="mainbody">The ribosomal binding site (RBS) of TPP ribozyme locates at the extended stem (shaded red in <strong>Fig.2</strong>). The <em>Schistosoma</em> hammerhead domain in TPP ribozyme could perform self-cleavage when posed in an appropriate conformation, and upon self-cleavage the RBS would be released from pairing, thus ribosome could get access to RBS and initiate translation of the downstream gene. Though similar in secondary structure, TPP ribozyme 1.20 and 2.5 undergo different mechanisms to regulate the translation of downstream gene. Upon addition of TPP, the aptamer domain would bind to TPP; while TPP ribozyme 1.20 would change to a conformation that is suitable for hammerhead domain to cleave itself, TPP ribozyme 2.5 would undergo a conformational change that would decelerate the self-cleaving rate of hammerhead domain. Therefore, upon adding TPP, TPP ribozyme 1.20 would facilitate the translation of downstream gene, whereas TPP ribozyme 2.5 would decrease the translation strength of downstream gene.</p> | + | |
| | <p class="mainbody"> </p> | | <p class="mainbody"> </p> |
| - | <p class="mainbody"> </p>
| |
| - | <p class="mainbody"><table width="600" border="0" cellspacing="0" cellpadding="0">
| |
| - | <tr>
| |
| - | <th width="4" rowspan="3" scope="col"> </th>
| |
| - | <th width="501" scope="col"> </th>
| |
| - | <th width="95" rowspan="3" scope="col"><span class="picturemark"><span class="mainbody"><img src="https://static.igem.org/mediawiki/2011/5/58/PekingR_Zyy13.jpg" width="500" align="center" height="434" /></span></span></th>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <th scope="col"> </th>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <th scope="col"> </th>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td colspan="3"><p align="left" class="picturemark"><strong>Figure.3</strong> <br />
| |
| - | Allosteric mechanism of TPP ribozymes. Upon self-cleavage the RBS would be released from pairing, thus ribosome could get access to RBS and initiate translation of the downstream gene .<strong>A) </strong>Mechanism for TPP ribozyme 1.20. Upon addition of TPP, TPP ribozyme 1.20 adopts a conformation that facilitates the self-cleavage of hammerhead domain. <strong>B)</strong> Mechanism for TPP ribozyme 2.5. When TPP added, TPP ribozyme 2.5 would change to a conformation that hinders the self-cleavage of hammerhead domain. Red: RBS sequence, blue: natural TPP aptamer, green: linker between aptamer and hammerhead domain, black: Schistosoma hammerhead ribozyme, red arrow: self-cleavage site. The figure is modified from<a href="#r304"> [3]</a>. </p><p align="left" class="picturemark"> </p></td>
| |
| - | </tr>
| |
| - | </table></p>
| |
| - | <p class="mainbody">We designed several experiments to demonstrate that TPP ribozymes are truly modular RNA controllers, independent of sequence context. The plasmids kindly provided by Prof. Hartig’s lab contain TPP ribozyme 1.20/2.5 with an upstream T7 promoter, and the downstream coding sequence is a copy of GFP gene, followed by a T7 terminator (<strong>Fig. 4-A</strong>). We termed these two constructs T7-1.20 and T7-2.5 respectively. To prove that the performance of TPP ribozymes is not relevant to the downstream coding sequence, we inserted first 36 base pairs of the coding sequence from Part BBa_E0040 ahead of the GFP coding sequence in the plasmid (<strong>Fig. 4-B</strong>). The two constructs were termed 36-1.20/36-2.5 respectively. </p>
| |
| - | <p class="mainbody"> </p>
| |
| - | <table width="200" border="0" cellspacing="0" cellpadding="0">
| |
| - | <tr>
| |
| - | <th scope="col"> </th>
| |
| - | <th scope="col"><img src="https://static.igem.org/mediawiki/2011/1/17/PekingR_Zyy9.png" width="600" height="960" /></th>
| |
| - | <th scope="col"> </th>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td> </td>
| |
| - | <td><p align="left" class="picturemark"><strong>Figure.4</strong><br />
| |
| - | Scheme of constructs designed to demonstrate the modularity of TPP ribozymes. <strong>A)</strong> T7-1.20/T7-2.5 consists of T7 promoter, TPP ribozyme, GFP and T7 terminator with native RBS. <strong> B)</strong> 36-1.20/36-2.5 were constructed by inserting the first 36 base pairs of BBa_E0040 between TPP ribozyme and GFP. <strong>C)</strong> pBAD-1.20/pBAD-2.5 consists of pBAD promoter, TPP ribozyme, BBa_E0040 and BBa_B0015 with native RBS (AAGGAGAT). <strong>D</strong><strong>）</strong>CI-1.20/CI-2.5 were constructed by adding the first 36 base pairs of CI ahead of coding sequence of E0040. <strong>E)</strong> TPP-RBS consists of pBAD promoter, native RBS, BBa_E0040 and BBa_B0015.</p></td>
| |
| - | <td> </td>
| |
| - | </tr>
| |
| - | </table>
| |
| - | <p class="mainbody">After transforming T7-1.20, T7-2.5, 36-1.20, 36-2.5 into <em>E. coli</em> DH5αcells, the bacteria were characterized in M9 medium with TPP concentration gradient. The result turned out that the corresponding working curves were similar, despite of different downstream coding sequence (<strong>Fig.5 & Fig.6</strong>, grids and curves in black and in red). </p>
| |
| - | <p class="mainbody">To further investigate whether the performance of TPP ribozymes is influenced by upstream promoter and downsteam terminator, we constructed two plasmids that contain TPP ribozyme 1.20/2.5 with an upstream pBAD promoter, and the downstream coding sequence is a GFP gene from Part BBa_E0040, followed by a terminator (Part:BBa_B0015) (<strong>Fig. 4-C</strong>). These two constructs were named pBAD-1.20 and pBAD-2.5 respectively. Similarly, we characterized these two constructs, and the working curves were also similar to those of T7-1.20/ T7-2.5 (<strong>Fig.5 & Fig.6</strong>, grids and curves in black and in blue). Another two plasmids were constructed by inserting first 36 base pairs of CI gene ahead of GFP coding sequence in pBAD-1.20/ pBAD-2.5 (<strong>Fig. 4-D</strong>). These are named CI-1.20 and CI-2.5 respectively. The working curves of these two constructs overlapped to a large extent with those of other constructs (<strong>Fig.5 & Fig.6</strong>, grids and curves in green), further demonstrating that the performance of TPP ribozyme 1.20 and 2.5 was independent of their coding sequence context, rendering them truly modular RNA devices to regulate gene expression. </p>
| |
| - | <table width="200" border="0" cellspacing="0" cellpadding="0">
| |
| - | <tr>
| |
| - | <th scope="col"> </th>
| |
| - | <th scope="col"><img src="https://static.igem.org/mediawiki/2011/6/68/PekingR_Zyyx.png" width="500" height="330" /></th>
| |
| - | <th scope="col"> </th>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td> </td>
| |
| - | <td><p align="left" class="picturemark"><strong>Figure.5 </strong>Working curves of TPP ribozyme 1.20 in different constructs. The activation ratio is </a>fluorescence intensity under given TPP concentrations compared to that of without TPP. Constructed plasmids were transformed into E. coli DH5a cells and characterized in M9 medium with a TPP concentration gradient of 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1, 3 mM. T7-1.20 and 36-1.20 were induced by 1mM IPTG. pBAD-1.20 and CI-1.20 were induced by 1mM arabinose. </p></td>
| |
| - | <td> </td>
| |
| - | </tr>
| |
| - | </table>
| |
| - | <p> </p>
| |
| - | <table width="200" border="0" cellspacing="0" cellpadding="0">
| |
| - | <tr>
| |
| - | <th scope="col"> </th>
| |
| - | <th scope="col"><img src="https://static.igem.org/mediawiki/2011/e/e9/PekingR_Zyy_fig6.png" width="500" height="330" /></th>
| |
| - | <th scope="col"> </th>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td> </td>
| |
| - | <td><p align="left" class="picturemark"><strong>Figure.6 </strong>Working curves of TPP ribozyme 2.5 in different constructs. The inhibition ratio is fluorescence intensity under given TPP concentrations compared to that of without TPP. Constructed plasmids were transformed into E. coli DH5a cells and characterized in M9 medium with a TPP concentration gradient of 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1, 3 <a name="OLE_LINK8" id="OLE_LINK8"></a><a name="OLE_LINK7" id="OLE_LINK7">m</a>M. T7-2.5 and 36-2.5 were induced by 1mM IPTG. pBAD-2.5 and CI-2.5 were induced by 1mM arabinose. </p></td>
| |
| - | <td> </td>
| |
| - | </tr>
| |
| - | </table>
| |
| - | <p class="mainbody">Additionally, to further confirm that the rise or drop of the working curves in <strong>Fig.5 </strong>or<strong> Fig.6 </strong>on different TPP concentrations was indeed the contribution of TPP ribozymes, we constructed a plasmid as control by substituting TPP ribozyme in pBAD-1.20/ pBAD-2.5 to the native RBS (AAGGAGAT) of TPP ribozyme, termed TPP-RBS (<strong>Fig.4-E</strong>). Similar characterization was performed, and the result showed that the fluorescence intensity produced by TPP-RBS fluctuated, yet not significant enough to show a trend to increase or decrease when TPP concentration went up, compared with the obvious fluorescence intensity change produced by pBAD-1.20/ pBAD-2.5 (<strong>Fig.7</strong>). Therefore, we can reach the conclusion that TPP ribozyme 1.20 and 2.5 functioned modularly to regulate downstream gene’s translation strength upon different concentrations of TPP. </p>
| |
| - | <table width="200" border="0" cellspacing="0" cellpadding="0">
| |
| - | <tr>
| |
| - | <th scope="col"> </th>
| |
| - | <th scope="col"><img src="https://static.igem.org/mediawiki/2011/4/4f/PekingR_Zyy_fig7.png" width="500" height="330" /></th>
| |
| - | <th scope="col"> </th>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td> </td>
| |
| - | <td><p align="left" class="picturemark"><strong>Figure.7 </strong>The fluorescence intensity of TPP-RBS, pBAD-1.20 and pBAD-2.5 under different TPP concentrations. Ordinate axis indicates the fluorescence intensity normalized by cell density. Constructed plasmids were transformed into E. coli DH5a cells and characterized in M9 medium with a TPP concentration gradient of 0, 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1, 3 mM, with induction by 1mM arabinose. </p></td>
| |
| - | <td> </td>
| |
| - | </tr>
| |
| - | </table>
| |
| - | <p> </p>
| |
| | <hr /> | | <hr /> |
| - | <p class="mainbody"><span class="Reference">Reference:</span><a name="r101" id="r101"></a><a name="r102" id="r102"></a><a name="r103" id="r103"></a><a name="r201" id="r201"></a><a name="r202" id="r202"></a><a name="r203" id="r203"></a><a name="r204" id="r204"></a><a name="r301" id="r301"></a><a name="r302" id="r302"></a><a name="r303" id="r303"></a><a name="r304" id="r304"></a></p>
| + | <div id="apDiv2"> |
| - | <p align="left" class="mainbody"><strong>[1]</strong> Monika Martick and William G.Scott. (2006). Tertiary Contacts Distant from<br />
| + | <table width=" 673" border="0" cellspacing="0" cellpadding="0"> |
| - | the Active Site Prime a Ribozyme for Catalysis. Cell 126, 309-320<br />
| + | <tr> |
| - | <strong>[2] </strong>Wade Winkler, Ali Nahvi Ronald R. Breaker. (2002). Thiamine Derivatives Bind Messenger RNAs Directly to Regulate Bacterial Gene Expression. Nature 419, 952-956<br />
| + | <th height="27" colspan="2" align="left" class="exist" scope="col">Existing Natural Genetic Rheostats</th> |
| - | <strong>[3]</strong> Markus Wieland, Armin Benz, Benedikt Klauser, and Jörg S. Hartig. (2009). Artificial Ribozyme Switches Containing Natural Riboswitch Aptamer Domains. Angew. Chem. 121, 2753-2756 </p>
| + | </tr> |
| - | <p class="mainbody"> </p>
| + | <tr> |
| - | <p class="mainbody"><span class="exist"><a href="#start">[TOP]</a></span></p>
| + | <td width="41" height="27" align="left"> </td> |
| - | <p class="mainbody"> </p>
| + | <td width="447" align="left" class=" TPP"><a href="https://2011.igem.org/Team:Peking_R/Project/ RNAToolkit1">TPP -regulated hammerhead ribozyme</a></td> |
| - | <p class="mainbody"> </p>
| + | </tr> |
| - | <p class="mainbody"> </p>
| + | <tr> |
| - | <p class="mainbody"> </p>
| + | <td height="28" align="left"> </td> |
| - | <p class="mainbody"> </p>
| + | <td align="left" class="TPP"><a href="https://2011.igem.org/Team:Peking_R/Project/RNAToolkit2"> Theophylline-responsive riboswitch</a></td> |
| - | </div>
| + | </tr> |
| - | <div id="apDiv3"> | + | <tr> |
| - | <table width=" 608" border="0" cellspacing="0" cellpadding="0"> | + | <td colspan="2" align="left" class="exist"><p>Engineered Genetic Rheostat</p></td> |
| - | <tr>
| + | </tr> |
| - | <th colspan="2" align="left" class="exist" scope="col">Existed Natural RNA Controllers</th>
| + | <tr> |
| - | </tr>
| + | <td height="27" align="left"> </td> |
| - | <tr>
| + | <td align="left" class="TPP"><a href="https://2011.igem.org/Team:Peking_R/Project/RNAToolkit3"> Engineered group I intron with a theophylline hammerhead ribozyme </a></td> |
| - | <td width="41" height="27" align="left"> </td>
| + | </tr> |
| - | <td width="447" align="left" class=" TPPQ1"><a href="https://2011.igem.org/Team:Peking_R/Project/ RNAToolkit">TPP</a> :regulated hammerhead ribozyme</td> | + | <tr> |
| - | </tr>
| + | <td height="33" align="left"> </td> |
| - | <tr>
| + | <td align="left" class="TPP"><a href="https://2011.igem.org/Team:Peking_R/Project/RNAToolkit4"> Adenine hammerhead ribozyme obtained from screening </a></td> |
| - | <td height="28" align="left"> </td>
| + | </tr> |
| - | <td align="left" class="TPP"><a href="https://2011.igem.org/Team:Peking_R/Project/RNAToolkit2"> THEOPHYLINE</a> : responsive rboswitch</td> | + | </table> |
| - | </tr>
| + | </div> |
| - | <tr>
| + | <p> </p> |
| - | <td colspan="2" align="left" class="exist"><p>Engineered RNA controllers</p></td> | + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td height="27" align="left"> </td>
| + | |
| - | <td align="left" class="TPP"><a href="https://2011.igem.org/Team:Peking_R/Project/RNAToolkit3"> RIBOZYME</a>:engineered group I intron with a theolline heammerhead ribozyme</td> | + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td height="33" align="left"> </td>
| + | |
| - | <td align="left" class="TPP"><a href="https://2011.igem.org/Team:Peking_R/Project/RNAToolkit4"> SELECTION</a>:adenine hammerhead ribozyme obtained from screening</td> | + | |
| - | </tr>
| + | |
| - | </table>
| + | |
| | </div> | | </div> |
| | </body> | | </body> |
| | </html> | | </html> |
"
